Atai life sciences to participate in upcoming may investor conference

New york and berlin, may 02, 2023 (globe newswire) -- atai life sciences (nasdaq: atai) (“atai”), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, will participate in the 2023 aegis virtual conference.
ATAI Ratings Summary
ATAI Quant Ranking